Senti Biosciences, Inc. SNTI announced positive initial data from a phase I study that evaluated its chimeric antigen ...

I formulated the missing-self hypothesis for natural killer (NK) cell recognition in the autumn of 1981, while writing the last chapter of my doctoral thesis. In 1975, I had joined the Department ...

About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a ...

Physical exercise plays an important role in controlling disease, including cancer, due to its effect on the human body’s ...

Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished ...

Senti Bio (SNTI)science reported positive initial clinical data from a Phase 1 clinical trial of SENTI-202, a potential first-in-class Logic Gated off-the-shelf chimeric antigen receptor natural kille ...

A randomized controlled trial found that carrageenan, a common food additive, may cause subclinical inflammation and insulin ...

The above-described awards were each granted as an inducement material to the employees entering into employment with the Company in accordance with NASDAQ Listing Rule 5635 (c) (4), and were granted ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that abstracts related to lacutamab health-related quality of life and translational data from the ...

Polymyositis is an autoimmune disease that causes inflammation and weakness of the skeletal muscles responsible for movement.